June 6, 2026 — S&P Dow Jones Indices announced it will retain its current eligibility criteria for companies seeking inclusion in the S&P 500, MidCap 400, and SmallCap 600 indexes. The decision, which follows extensive feedback from market participants, maintains requirements for U.S. headquarters, exchange listing, and a mandatory 12-month trading period after an initial public offering (IPO). This contrasts with Nasdaq’s recent move to accelerate the inclusion of large IPO companies into its Nasdaq 100 index.
The index provider emphasized that the current rules ensure balanced market coverage and sector representation. The announcement comes amid heightened anticipation for major IPOs from AI and technology firms such as SpaceX, Anthropic, and OpenAI. Index inclusion is a critical milestone for institutional investors like pension funds and mutual funds, as it often triggers significant passive fund inflows.
SpaceX IPO Could Reshape ETF Landscape
SpaceX is planning a historic IPO that could raise $75 billion at a $1.8 trillion valuation. While it may not crack the top holdings of broad growth ETFs like Vanguard Growth, analysts predict it could quickly become a top-three holding in the Vanguard Communication Services ETF. This is because SpaceX’s primary communications business, Starlink, generates the bulk of its revenue from satellite broadband, aligning it with the communication services sector under the Global Industry Classification Standard (GICS). The company’s ownership of X (formerly Twitter) further reinforces this classification. The IPO and subsequent index inclusion could significantly disrupt market capitalizations and ETF compositions by mid-2024.
Ally Financial Seen as Undervalued
Ally Financial (NYSE: ALLY) has seen its share price decline 3.5% over the past month and 6.5% year-to-date, yet it has delivered a 21.4% return over the past year. Despite short-term softness, valuation models suggest the stock is undervalued. The Excess Returns model values Ally at approximately $59.13 per share, 27.7% above the current price of $42.77, based on stable book value and future earnings expectations. Analysts note the stock scores 5 out of 6 on undervaluation metrics, suggesting potential upside for investors willing to look beyond near-term sentiment.
Paladin Energy Joins S&P/ASX 100
S&P Dow Jones Indices also announced the June 2026 rebalance for Australian indexes. Paladin Energy Limited (ASX: PDN) will enter the S&P/ASX 100, while ALS Limited joins the S&P/ASX 50. Metcash and Pro Medicus are removed. The S&P/ASX 200 gains new resource and tech stocks, while several consumer, education, and tech firms are dropped. The S&P/ASX All Technology Index will exclude Acusensus, EROAD, and FINEOS. These changes, effective June 22, reflect market performance and size adjustments, impacting liquidity and investor portfolios. Paladin Energy, an Australian uranium producer with a market cap of A$5.32 billion, is rated a Strong Buy with a A$15.00 target.
Crypto Market Poised for Rally
The cryptocurrency market, which has endured an eight-month bear phase since a $19 billion crash in October 2025, may be poised for a powerful rally. Historically, crypto bear markets last 10 to 14 months, with capital rotating into new leaders during downturns. Three coins stand out: Hyperliquid (HYPE), a decentralized derivatives exchange with $139 million in ETF assets and token buyback incentives; privacy-focused Zcash (ZEC), which offers transaction anonymity but raises regulatory concerns; and Bittensor (TAO), a blockchain supporting incentive-based computing services. These developments suggest a potential shift in investor sentiment and market dynamics, challenging the pervasive bearish outlook.
Judges Scientific Shares Drop 26%
Judges Scientific (LSE: JDG), a UK growth stock, has fallen 26% this year amid weak demand for scientific instruments and uncertain U.S. federal research funding. Despite these headwinds, the company remains optimistic about a funding recovery and upcoming profitable coring expeditions from its Geotek subsidiary, though none are expected in 2026. The business’s high-cost, technical equipment contributes to cyclical sales fluctuations but also poses significant barriers to entry. Analysts and investors remain cautiously optimistic, viewing current share prices as attractive buying opportunities for long-term gains.
